AVR
Anteris Technologies Global Corp.
Healthcare · Medical Instruments & Supplies · NGM
$8.86
Close 2026-05-28
✓ ETHICAL PASS

UNKNOWN MOAT
HIGH
Data Confidence: 86%
Full financial profile available
Market Cap
$862.5M
Trailing P/E
Forward P/E
-8.07
Rev Growth
-11.2%
Profit Margin
0.0%
ROE
-59.2%
Analyst Target
$15.50
Recommendation
STRONG BUY
About Anteris Technologies Global Corp.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Ethical Screen
Business ActivityPASS
Debt RatioN/A
Cash RatioN/A
Receivables RatioN/A
Revenue Ratio (0.00%)PASS
OverallPASS
Score Ethical: 64.7
Score Valuation: 33.0
Score Quality: 15.0
Score Combined: 33.4

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation50.0
Quality0.0
Cash Flow0.0
Moat40.0
Balance Sheet50.4
Debt Purity50.0
Liquid Purity50.0
Rev Purity100.0
Compliance100.0
Tier: WATCH · Score: 38.0 · Rank: #4461
Insider Transactions
No insider transaction data.
Top Institutional Holders
No institutional holder data.
Additional Fundamentals
Enterprise Value
$574.7M
Price/Book
3.06
Beta
0.590
Analysts
4
Total Revenue (TTM)
$1.9M
Total Debt
$3.7M
Rec. Mean
1.25
Short Ratio
5.69
Short % Float
0.1%
Employees
174

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite
Trade Consideration
The Opportunity
Score 33.4 (P26 — top 74.2% of scored tickers). Unknown Moat. Ethical PASS. 4 analysts at Strong Buy.
Price: $8.86 | Target: $16.00 (+81%)
Score
33
Moat
Unknown
Conviction
Standard
Upside
+81%
The Fundamentals
Revenue Growth-11.2%
Profit Margin0.0%
ROE-59.2%
Forward P/E-8.1
Market Cap$862.5M
Position Sizing Scenarios
Stop: $7.53 (-15%) | Entry: $8.86
SharesCostProfit to TargetR:R
To Consensus ($16.00, 4 analysts)
10$88.60+$71.40 (81%)5.4R
50$443.00+$357.00 (81%)5.4R
100$886.00+$714.00 (81%)5.4R
Risk Factors
  • Elevated short interest (5.69 days to cover)
The Verdict
Anteris Technologies Global Corp. passes all ethical screens and holds a unknown competitive moat.
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

A
Quant Score
71.1
Risk Grade
Layers
7
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-8.2%
worst expected daily loss, 19 in 20 days
CVaR 95%
-10.5%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
0.64
above 1.0 is good
Max Drawdown
-71.5%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
55
Liquidity Grade
MODERATE
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
ABOVE_200
Bollinger Position
NEAR_UPPER
Beta
Relative Volume
0.5x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
IWM0.373
CTS0.366
BLCO0.360
QQEW0.357
ADJEX0.350
Inverse Correlated
TickerCorrelation
MIDAN.KW-0.174
8060.SR-0.165
CBOE-0.162
SPEC.KW-0.161
BTTX-0.161
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Tuesday
Worst Day
Friday
Best Month
Aug
Worst Month
Mar
Fri-Mon Effect
-0.5566715259323101
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
+54.4%
3M Return
+38.3%
6M Return
+135.1%
12M Return
+82.7%
Momentum Rank
#186
Momentum Signal
STRONG_UP

Get our daily market read free. Join thousands of traders.

Free Explorer Access